Nagaoka Red Cross Hospital

Nagaoka, Niigata 940-2108

0 studies enrolling now · 3 studies all time

What they study most

Arthritis, Autoimmune Diseases, Connective Tissue Diseases, End-stage Renal Disease, Hemodiafiltration, Hemodialysis, Immune System Diseases, Joint Diseases, Musculoskeletal Diseases, Prevention of Thromboembolic Events, Rheumatic Diseases, Rheumatoid Arthritis

Studies at this site

• A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis — Stopped early
• Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis — Completed
• An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis — Completed